Home NCDEX Emcure Pharma IPO lists at 31% premium on NSE NCDEX Emcure Pharma IPO lists at 31% premium on NSE By - July 10, 2024 27 0 FacebookTwitterPinterestWhatsApp Emcure IPO opened on July 3 and closed on July 5. It is a book-built issue valued at ₹1,952.03 crores. RELATED ARTICLESMORE FROM AUTHOR NCDEX Latest Business News, Live Updates Today July 21, 2024 NCDEX Lighter bags, heavier hearts: Home, restaurant kitchens feel pinch of vegetable price rise NCDEX Economic Survey to be tabled in Parliament today ahead of Budget: 10 points LEAVE A REPLY Cancel reply Please enter your comment! Please enter your name here You have entered an incorrect email address! Please enter your email address here Save my name, email, and website in this browser for the next time I comment. - Advertisement - APPLICATIONS BJP leader shot dead by suspected Maoists in Chhattisgarh’s Narayanpur district - February 11, 2023 ‘One Gautam did tapasya, another one…’: Congress continues tirade on Adani - February 17, 2023 Getting married on Jan 22? Alas! wedding bands in Delhi are overbooked that day - January 18, 2024 Gold prices on April 2: Check rates in Delhi, Mumbai, Kolkata, Chennai, Pune here - April 2, 2024 HOT NEWS ‘Not having sex with spouse for long time a form of... - May 26, 2023 0 News 'Not having sex with spouse for long time a form of mental cruelty, says Allahabad High Court: Report The husband sought a divorce on grounds of mental cruelty, divorce agreement and long desertion.